Safety Study of BMS-823778 in Subjects With Hypercholesterolemia

Completed · Phase 2 · Has a placebo group

Conditions studied: Dyslipidemia

In brief

The purpose of this study is to assess the safety, tolerability and pharmacodynamic effects on LDL cholesterol (LDL-C)

Key facts

Study ID: NCT01112423
Run by: Bristol-Myers Squibb
People needed: 60
Starts: 2010-06-01
Expected to finish: 2010-12-01
Last updated by the study team: 2015-10-12

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

Hypercholesterolemia
Currently taking a stable daily dose of statin therapy
Serum triglyceride level < 500mg/dl

You may not qualify if…

History of myocardial infarction, coronary angioplasty or bypass grafts, valvular disease or repair, unstable angina pectoris, transient ischemic attack, or cerebrovascular accidents within six months prior to entry into the study
Congestive heart failure
Diabetes mellitus
Active liver disease
Impaired renal function
Hepatitis C, B and HIV
This list is not inclusive; additional information is provided in the protocol

Where it is running

Osborne Research Center — Little Rock, Arkansas, United States
Pra International — Lenexa, Kansas, United States
Sterling Research Grp, Ltd. — Cincinnati, Ohio, United States
Cetero Research - San Antonio — San Antonio, Texas, United States
National Clinical Research - Norfolk, Inc. — Norfolk, Virginia, United States
National Clinical Research - Richmond, Inc. — Richmond, Virginia, United States
Local Institution — Brisbane, Queensland, Australia
Local Institution — Winnipeg, Manitoba, Canada
Local Institution — Mount Pearl, Newfoundland and Labrador, Canada
Local Institution — London, Ontario, Canada
Local Institution — Drummondville, Quebec, Canada
Local Institution — Montreal, Quebec, Canada

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.